Most are gastrointestinal, including nausea, vomiting, diarrhea, constipation, or abdominal discomfort, but some symptoms may signal dehydration, kidney stress, gallbladder disease, pancreatitis, hypoglycemia, or another problem that requires medical evaluation
Slight deviations in systemic exposure can precipitate hypoglycemia (if exposure is too high) or loss of glycemic control (if exposure is too low), outcomes that are immediate and potentially life-threatening ( 4.3 Bioequivalence standards and regulatory reality Bioequivalence standards further compound this problem
No cost to apply 100% private 94.6% of members hit their goal If you don't hit your goal weight we pay for it.* Most GLP-1 providers can't afford to offer this
Wegovy pill for weight loss In December 2025, Wegovy released a once-daily pill formulation for weight loss in adults
Most people experience steady progress, with significant weight loss becoming evident after three months